Zoran Erjavec
Delfzijl, GR, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A critical view of the BJH publication on the lack of benefit of second-line daratumumab in patients with functional high-risk multiple myeloma.
Journal: British journal of haematology
Published: March 02, 2026
Clinical Benefit of Early Daratumumab Use in Multiple Myeloma is Undefined.
Journal: American journal of hematology
Published: April 07, 2025
Quality of life gains in frail and intermediate-fit patients with multiple Myeloma: Findings from the prospective HOVON123 clinical trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 02, 2024
Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study.
Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Published: June 01, 2015
Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group.
Journal: Lancet (London, England)
Published: April 12, 2015
Randomised study of tegafur-uracil plus leucovorin versus capecitabine as first-line therapy in elderly patients with advanced colorectal cancer--TLC study.
Journal: Journal of geriatric oncology
Published: December 21, 2014
Real-world costs of chronic lymphocytic leukaemia in the Netherlands.
Journal: Leukemia research
Published: September 14, 2013
Analysis of docetaxel therapy in elderly (≥70 years) castration resistant prostate cancer patients enrolled in the Netherlands Prostate Study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 15, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026